Literature DB >> 15545287

Identification of R(-)-isomer of efonidipine as a selective blocker of T-type Ca2+ channels.

Taiji Furukawa1, Reiko Miura, Mitsuyoshi Honda, Natsuko Kamiya, Yasuo Mori, Satoshi Takeshita, Takaaki Isshiki, Toshihide Nukada.   

Abstract

Efonidipine, a derivative of dihydropyridine Ca(2+) antagonist, is known to block both L- and T-type Ca(2+) channels. It remains to be clarified, however, whether efonidipine affects other voltage-dependent Ca(2+) channel subtypes such as N-, P/Q- and R-types, and whether the optical isomers of efonidipine have different selectivities in blocking these Ca(2+) channels, including L- and T-types. To address these issues, the effects of efonidipine and its R(-)- and S(+)-isomers on these Ca(2+) channel subtypes were examined electrophysiologically in the expression systems using Xenopus oocytes and baby hamster kidney cells (BHK tk-ts13). Efonidipine, a mixture of R(-)- and S(+)-isomers, exerted blocking actions on L- and T-types, but no effects on N-, P/Q- and R-type Ca(2+) channels. The selective blocking actions on L- and T-type channels were reproduced by the S(+)-efonidipine isomer. By contrast, the R(-)-efonidipine isomer preferentially blocked T-type channels. The blocking actions of efonidipine and its enantiomers were dependent on holding potentials. These findings indicate that the R(-)-isomer of efonidipine is a specific blocker of the T-type Ca(2+) channel.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15545287      PMCID: PMC1575949          DOI: 10.1038/sj.bjp.0705944

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  39 in total

1.  The alpha(1G)-subunit of a voltage-dependent Ca(2+) channel is localized in rat distal nephron and collecting duct.

Authors:  D Andreasen; B L Jensen; P B Hansen; T H Kwon; S Nielsen; O Skøtt
Journal:  Am J Physiol Renal Physiol       Date:  2000-12

2.  Inactivation determinants in segment IIIS6 of Ca(v)3.1.

Authors:  R Marksteiner; P Schurr; S Berjukow; E Margreiter; E Perez-Reyes; S Hering
Journal:  J Physiol       Date:  2001-11-15       Impact factor: 5.182

Review 3.  Molecular physiology of low-voltage-activated t-type calcium channels.

Authors:  Edward Perez-Reyes
Journal:  Physiol Rev       Date:  2003-01       Impact factor: 37.312

4.  T-channel-selective calcium channel blockade: a promising therapeutic possibility, only preliminarily tested so far: a review of published data. T-Channel Calcium Channel Blocker Study Group.

Authors:  J A Van der Vring; T J Cleophas; E E Van der Wall; M G Niemeyer
Journal:  Am J Ther       Date:  1999-07       Impact factor: 2.688

5.  A region of the sulfonylurea receptor critical for a modulation of ATP-sensitive K(+) channels by G-protein betagamma-subunits.

Authors:  Y Wada; T Yamashita; K Imai; R Miura; K Takao; M Nishi; H Takeshima; T Asano; R Morishita; K Nishizawa; S Kokubun; T Nukada
Journal:  EMBO J       Date:  2000-09-15       Impact factor: 11.598

6.  Molecular cloning and functional expression of Ca(v)3.1c, a T-type calcium channel from human brain.

Authors:  L L Cribbs; J C Gomora; A N Daud; J H Lee; E Perez-Reyes
Journal:  FEBS Lett       Date:  2000-01-21       Impact factor: 4.124

7.  Selectivities of dihydropyridine derivatives in blocking Ca(2+) channel subtypes expressed in Xenopus oocytes.

Authors:  T Furukawa; T Yamakawa; T Midera; T Sagawa; Y Mori; T Nukada
Journal:  J Pharmacol Exp Ther       Date:  1999-11       Impact factor: 4.030

8.  Regulation of calcium channel activity by lipid domain formation in planar lipid bilayers.

Authors:  Brian Cannon; Martin Hermansson; Sandor Györke; Pentti Somerharju; Jorma A Virtanen; Kwan Hon Cheng
Journal:  Biophys J       Date:  2003-08       Impact factor: 4.033

Review 9.  Efonidipine hydrochloride: a dual blocker of L- and T-type ca(2+) channels.

Authors:  Hikaru Tanaka; Koki Shigenobu
Journal:  Cardiovasc Drug Rev       Date:  2002

10.  Clinical efficacy of efonidipine hydrochloride, a T-type calcium channel inhibitor, on sympathetic activities.

Authors:  Kenji Harada; Masahiro Nomura; Akiyoshi Nishikado; Kouzoh Uehara; Yutaka Nakaya; Susumu Ito
Journal:  Circ J       Date:  2003-02       Impact factor: 2.993

View more
  17 in total

Review 1.  T-type calcium channels and vascular function: the new kid on the block?

Authors:  Ivana Y-T Kuo; Stephanie E Wölfle; Caryl E Hill
Journal:  J Physiol       Date:  2010-12-20       Impact factor: 5.182

Review 2.  Vascular effects of calcium channel antagonists: new evidence.

Authors:  Sylvain Richard
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 3.  Development of newer calcium channel antagonists: therapeutic potential of efonidipine in preventing electrical remodelling during atrial fibrillation.

Authors:  Narutaka Ohashi; Hideo Mitamura; Satoshi Ogawa
Journal:  Drugs       Date:  2009       Impact factor: 9.546

4.  Molecular pharmacology of human Cav3.2 T-type Ca2+ channels: block by antihypertensives, antiarrhythmics, and their analogs.

Authors:  Edward Perez-Reyes; Amy L Van Deusen; Iuliia Vitko
Journal:  J Pharmacol Exp Ther       Date:  2008-10-30       Impact factor: 4.030

5.  A molecular signature of tissues with pacemaker activity in the heart and upper urinary tract involves coexpressed hyperpolarization-activated cation and T-type Ca2+ channels.

Authors:  Romulo Hurtado; Gil Bub; Doris Herzlinger
Journal:  FASEB J       Date:  2013-11-04       Impact factor: 5.191

6.  Modulation of subthalamic T-type Ca(2+) channels remedies locomotor deficits in a rat model of Parkinson disease.

Authors:  Chun-Hwei Tai; Ya-Chin Yang; Ming-Kai Pan; Chen-Syuan Huang; Chung-Chin Kuo
Journal:  J Clin Invest       Date:  2011-08       Impact factor: 14.808

7.  Identification of L- and T-type Ca2+ channels in rat cerebral arteries: role in myogenic tone development.

Authors:  Rasha R Abd El-Rahman; Osama F Harraz; Suzanne E Brett; Yana Anfinogenova; Rania E Mufti; Daniel Goldman; Donald G Welsh
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-10-26       Impact factor: 4.733

8.  Analgesic effect of a broad-spectrum dihydropyridine inhibitor of voltage-gated calcium channels.

Authors:  Vinicius M Gadotti; Chris Bladen; Fang Xiong Zhang; Lina Chen; Miyase Gözde Gündüz; Rahime Şimşek; Cihat Şafak; Gerald W Zamponi
Journal:  Pflugers Arch       Date:  2015-08-19       Impact factor: 3.657

9.  1,4-Dihydropyridine derivatives with T-type calcium channel blocking activity attenuate inflammatory and neuropathic pain.

Authors:  Chris Bladen; Vinicius M Gadotti; Miyase G Gündüz; N Daniel Berger; Rahime Şimşek; Cihat Şafak; Gerald W Zamponi
Journal:  Pflugers Arch       Date:  2014-07-03       Impact factor: 3.657

10.  A selective T-type Ca2+ channel blocker R(-) efonidipine.

Authors:  Min-Chul Shin; Chang-Ju Kim; Byung-Il Min; Sachie Ogawa; Eiichiro Tanaka; Norio Akaike
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-02-16       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.